Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Single-Chamber Prefilled Syringes Market Set To Climb From $13.93 Billion In 2026 To $25.79 Billion By 2030
The market for single-chamber prefilled syringes has seen rapid expansion in recent years. It is forecast to increase from $11.97 billion in 2025 to $13.93 billion in 2026, with a compound annual growth rate (CAGR) of 16.4%. This historical growth can be attributed to several factors including the rise in injectable drug formulations, an increase in vaccination programs, the broadening of biologics manufacturing, a heightened focus on patient safety standards, and the availability of advanced packaging materials.
The single-chamber prefilled syringes market size is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $25.79 billion, exhibiting a compound annual growth rate (CAGR) of 16.7%. This projected growth during the forecast period is fueled by several factors, including a surge in demand for self-administered injectable medications, the expanding pipeline of biologics, the rise of drug administration at home, a heightened emphasis on eco-friendly packaging solutions, and the wider embrace of prefilled syringes in developing economies. Key trends expected over this period involve the greater integration of prefilled drug delivery systems, a heightened need for ready-to-use injectable formulations, an increase in the utilization of plastic for syringe construction, broader applications for vaccine and biologic packaging, and a sharpened focus on precise dosing and ensuring patient safety.
Get A Free Sample Report With In-Depth Market Insights:
Single-Chamber Prefilled Syringes Market Demand Drivers: What’s Powering Industry Growth?
The single-chamber prefilled syringe market is experiencing growth driven by the rising prevalence of chronic conditions such as diabetes and cancer. Patients with diabetes who require insulin therapy when medications cannot adequately control their blood glucose levels utilize the single-chamber prefilled syringe. The increasing incidence of chronic diseases like diabetes and cancer is primarily due to progressively sedentary lifestyles, which disrupt metabolic balance and reduce long-term physiological resilience, ultimately elevating the risk of chronic illness. Single-chamber prefilled syringes aid in managing chronic diseases such as diabetes and cancer by enabling quick, accurate, and convenient administration of injectable therapies, thereby improving treatment adherence and decreasing dosing errors during extended care. For instance, in February 2024, the World Health Organization, a Switzerland-based specialized agency responsible for international public health, projected over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases such as diabetes and cancer is a significant factor driving the market for single-chamber prefilled syringes.
Single-Chamber Prefilled Syringes Market Segment Analysis: What Are The Core Market Categories?
The single-chamber prefilled syringes market covered in this report is segmented –
1) By Type: Glass, Plastic
2) By Application: Vaccine Product, Biologic, Pharmaceutical Product
3) By End-User: Hospitals And Clinics, Ambulatory Care Centers And Specialty Clinics, Home Healthcare And Self-Administration
Subsegments:
1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes
2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes
Single-Chamber Prefilled Syringes Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies operating in the Single-Chamber Prefilled Syringes market are prioritizing the creation of innovative polymer-based single-dose prefilled syringe systems. This development is driven by the increasing demand for scalable, cost-effective, and safe injectable delivery formats, fueled by the rising use of biologics and the trend towards home self-administration. Polymer prefilled syringes are manufactured using materials like cyclic-olefin polymer (COP) or cyclic-olefin copolymer (COC), which provide excellent drug stability and inertness along with a lower risk of breakage compared to traditional glass syringes. For instance, in January 2023, Sharps Technology, Inc., a U.S.-based medical device and pharmaceutical-packaging company, announced its plan to introduce next-generation specialty polymer prefillable syringe systems. These systems are being manufactured in cooperation with Nephron Pharmaceuticals, utilizing COP and COC materials. These advanced syringes are engineered to reduce contamination, minimize dead space, and eliminate breakage risk, while maintaining compatibility with existing fill-finish lines. They are also free from silicon, which helps to reduce aggregation risk, making them safer and more reliable. Source: Sharps Technology press release.
Single-Chamber Prefilled Syringes Market Top Companies Driving Competitive Growth
Major companies operating in the single-chamber prefilled syringes market are Becton Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.
View The Full Single-Chamber Prefilled Syringes Market Report:
Single-Chamber Prefilled Syringes Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the single-chamber prefilled syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-chamber prefilled syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
